-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, GHFM4qDZPvJg6Np6S1AWwVuQQU1uyYKcdqdxCQjhm8rzFjmQMsp1npMW49Sc6Rgi m3QA49WBorM18Enrs3rm/w== 0001005477-04-001292.txt : 20040322 0001005477-04-001292.hdr.sgml : 20040322 20040322161230 ACCESSION NUMBER: 0001005477-04-001292 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20040318 FILED AS OF DATE: 20040322 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SHERMAN BERNARD C CENTRAL INDEX KEY: 0000936837 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-09860 FILM NUMBER: 04682646 BUSINESS ADDRESS: STREET 1: HARTMAN & CRAVEN LLP STREET 2: 460 PARK AVENUE CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 4167499300 MAIL ADDRESS: STREET 1: 150 SIGNET DR STREET 2: WESTON ONTARIO CITY: CANADA M9L 1T9 STATE: A6 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BARR PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000010081 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 221927534 STATE OF INCORPORATION: NY FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 2 QUAKER RD BOX 2900 CITY: POMONA STATE: NY ZIP: 10970-0519 BUSINESS PHONE: 8453621100 MAIL ADDRESS: STREET 1: 2 QUAKER RD STREET 2: BOX 2900 CITY: POMONA STATE: NY ZIP: 10970-0519 FORMER COMPANY: FORMER CONFORMED NAME: BARR LABORATORIES INC DATE OF NAME CHANGE: 19920703 4 1 edgar123.xml FORM 4 X0201 4 2004-03-18 0 0000010081 BARR PHARMACEUTICALS INC BRL 0000936837 SHERMAN BERNARD C 150 SIGNET DRIVE WESTON, ONTARIO A6 M9L IT9 ONTARIO, CANADA 0 0 1 0 Common Stock 2004-03-18 4 S 0 84400 48.9 D 13376100 I By Sherman Delaware, Inc. Common Stock 2004-03-18 4 S 0 5500 48.91 D 13370600 I By Sherman Delaware, Inc. Common Stock 2004-03-18 4 S 0 1600 48.92 D 13369000 I By Sherman Delaware, Inc. Common Stock 2004-03-18 4 S 0 4300 48.93 D 13364700 I By Sherman Delaware, Inc. Common Stock 2004-03-18 4 S 0 7000 48.94 D 13357700 I By Sherman Delaware, Inc. Common Stock 2004-03-18 4 S 0 2000 48.96 D 13355700 I By Sherman Delaware, Inc. Common Stock 2004-03-18 4 S 0 40200 49 D 13315500 I By Sherman Delaware, Inc. Bernard C. Sherman directly owns 16,875 shares of common stock. /s/ Bernard C. Sherman 2004-03-22 EX-99 3 ex99.txt JOINT FILER INFORMATION JOINT FILER INFORMATION This Form 4 is being filed jointly by the following parties: (i) Bernard C. Sherman ("Dr. Sherman"), who directly owns 11,250 shares of Barr Pharmaceuticals, Inc. (the "Issuer"), who has sole voting and dispositive control, as the sole trustee, of The Bernard Sherman 2000 Trust ("Sherman Trust"), and who owns 99% of the Outstanding capital stock of Sherman Holdings Inc. ("Sherman Holdings"); (ii) Sherman Trust which owns 99% of the common stock of Shermco, Inc. ("Shermco"); (iii) Sherman Holdings which owns 99% of the preferred stock of Shermco; (iv) Shermco which owns all of the outstanding capital stock of Sherfam Inc. ("Sherfam"); (v) Sherfam which owns all the outstanding capital stock of Apotex Holdings Inc. ("Apotex"); (vi) Apotex which owns all of the outstanding capital stock of SHERMFIN, INC. ("Shermfin"); (vii) Shermfin which owns all of the outstanding capital stock of Sherman Delaware, Inc. ("SDI"); (viii) SDI which directly owns, as of the date of this filing, 13,315,500 shares of common stock of the Issuer. Pursuant to Rule 16a-1(a)(4), the filing of this Form 4 shall not be deemed to be an admission by Dr. Sherman, Sherman Trust, Sherman Holdings, Shermco, Sherfam, Apotex and Shermfin that any of Dr. Sherman, Sherman Trust, Sherman Holdings, Shermco, Sherfam, Apotex and Shermfin is, for the purposes of Section 16 of the Securities Exchange Act of 1934, the beneficial owner of any securities covered by this Form 4. Name: Dr. Bernard C. Sherman Address: 150 Signet Drive, Weston, Ontario, Canada M9L 1T9 Designated Filer: Sherman Delaware, Inc. Issuer and Ticker Symbol: Barr Pharmaceuticals, Inc. (BRL) Date of Event Requiring Statement: March 18, 2004 /s/ Bernard C. Sherman Bernard C. Sherman Name: The Bernard Sherman 2000 Trust Name: Apotex Holdings Inc. Address: 150 Signet Drive, Weston, Address: 150 Signet Drive, Weston, Ontario, Canada M9L 1T9 Ontario, Canada M9L 1T9 Designated Filer: Sherman Delaware, Inc. Designated Filer: Sherman Delaware, Inc. Issuer and Ticker Symbol: Barr Issuer and Ticker Symbol: Barr Pharmaceuticals, Inc. (BRL) Pharmaceuticals, Inc. (BRL) Date of Event Date of Event Requiring Statement: March 18, 2004 Requiring Statement: March 18, 2004 By: /s/ Bernard C. Sherman By: /s/ Bernard C. Sherman ------------------ ------------------ Bernard C. Sherman Bernard C. Sherman Sole Trustee President
Name: Sherman Holdings Inc. Name: SHERMFIN, INC. Address: 150 Signet Drive, Weston, Address: 150 Signet Drive, Weston, Ontario, Canada M9L 1T9 Ontario, Canada M9L 1T9 Designated Filer: Sherman Delaware, Inc. Designated Filer: Sherman Delaware, Inc. Issuer and Ticker Symbol: Barr Issuer and Ticker Symbol: Barr Pharmaceuticals, Inc. (BRL) Pharmaceuticals, Inc. (BRL) Date of Event Date of Event Requiring Statement: March 18, 2004 Requiring Statement: March 18, 2004 By: /s/ Bernard C. Sherman By: /s/ Bernard C. Sherman ------------------ ------------------ Bernard C. Sherman Bernard C. Sherman President President Name: Shermco Inc. Name: Sherfam Inc. Address: 150 Signet Drive, Weston, Address: 150 Signet Drive, Weston, Ontario, Canada M9L 1T9 Ontario, Canada M9L 1T9 Designated Filer: Sherman Delaware, Inc. Designated Filer: Sherman Delaware, Inc. Issuer and Ticker Symbol: Barr Issuer and Ticker Symbol: Barr Pharmaceuticals, Inc. (BRL) Pharmaceuticals, Inc. (BRL) Date of Event Date of Event Requiring Statement: March 18, 2004 Requiring Statement: March 18, 2004 By: /s/ Bernard C. Sherman By: /s/ Bernard C. Sherman ------------------- ------------------ Bernard C. Sherman Bernard C. Sherman Chairman Chairman
-----END PRIVACY-ENHANCED MESSAGE-----